Literature DB >> 2972691

Low plasma immunoreactive beta-endorphin levels in autism.

R Weizman, I Gil-Ad, J Dick, S Tyano, G A Szekely, Z Laron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2972691     DOI： 10.1097/00004583-198807000-00009

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN： 0890-8567            Impact factor:   8.829


× No keyword cloud information.
  6 in total

1.  Brief report: a double-blind study of naltrexone in infantile autism.

Authors:  M Leboyer; M P Bouvard; J M Launay; F Tabuteau; D Waller; M Dugas; B Kerdelhue; P Lensing; J Panksepp
Journal:  J Autism Dev Disord       Date:  1992-06

Review 2.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

Review 3.  [Autism and pain - a literature review].

Authors:  Amandine Dubois; Cécile Rattaz; René Pry; Amaria Baghdadli
Journal:  Pain Res Manag       Date:  2010 Jul-Aug       Impact factor: 3.037

4.  Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters.

Authors:  Barbara Stanley; Leo Sher; Scott Wilson; Rolf Ekman; Yung-yu Huang; J John Mann
Journal:  J Affect Disord       Date:  2009-11-25       Impact factor: 4.839

Review 5.  The Current View on the Paradox of Pain in Autism Spectrum Disorders.

Authors:  Olena V Bogdanova; Volodymyr B Bogdanov; Adrien Pizano; Manuel Bouvard; Jean-Rene Cazalets; Nicholas Mellen; Anouck Amestoy
Journal:  Front Psychiatry       Date:  2022-07-22       Impact factor: 5.435

6.  Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.

Authors:  Sylvie Tordjman; George M Anderson; Michel Botbol; Sylvie Brailly-Tabard; Fernando Perez-Diaz; Rozenn Graignic; Michèle Carlier; Gérard Schmit; Anne-Catherine Rolland; Olivier Bonnot; Séverine Trabado; Pierre Roubertoux; Guillaume Bronsard
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.